- Home
- SEVN vs LFCR Comparison
SEVN vs LFCR Comparison
Compare SEVN & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEVN
- LFCR
- Stock Information
- Founded
- SEVN 1986
- LFCR 1986
- Country
- SEVN United States
- LFCR United States
- Employees
- SEVN N/A
- LFCR N/A
- Industry
- SEVN Real Estate Investment Trusts
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- SEVN Real Estate
- LFCR Health Care
- Exchange
- SEVN Nasdaq
- LFCR Nasdaq
- Market Cap
- SEVN 198.5M
- LFCR 214.7M
- IPO Year
- SEVN N/A
- LFCR N/A
- Fundamental
- Price
- SEVN $13.26
- LFCR $6.48
- Analyst Decision
- SEVN Strong Buy
- LFCR Buy
- Analyst Count
- SEVN 3
- LFCR 3
- Target Price
- SEVN $14.50
- LFCR $8.00
- AVG Volume (30 Days)
- SEVN 51.1K
- LFCR 379.4K
- Earning Date
- SEVN 02-18-2025
- LFCR 01-02-2025
- Dividend Yield
- SEVN 10.56%
- LFCR N/A
- EPS Growth
- SEVN N/A
- LFCR N/A
- EPS
- SEVN 1.28
- LFCR N/A
- Revenue
- SEVN $30,401,000.00
- LFCR $130,858,000.00
- Revenue This Year
- SEVN N/A
- LFCR $2.24
- Revenue Next Year
- SEVN N/A
- LFCR $7.88
- P/E Ratio
- SEVN $10.36
- LFCR N/A
- Revenue Growth
- SEVN N/A
- LFCR 16.47
- 52 Week Low
- SEVN $11.23
- LFCR $3.68
- 52 Week High
- SEVN $14.66
- LFCR $8.90
- Technical
- Relative Strength Index (RSI)
- SEVN 57.52
- LFCR 45.69
- Support Level
- SEVN $12.63
- LFCR $6.13
- Resistance Level
- SEVN $12.75
- LFCR $6.58
- Average True Range (ATR)
- SEVN 0.39
- LFCR 0.57
- MACD
- SEVN 0.05
- LFCR -0.06
- Stochastic Oscillator
- SEVN 86.53
- LFCR 40.69
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.